Free Trial
ETR:CCAP

CORESTATE Capital (CCAP) Stock Price, News & Analysis

CORESTATE Capital logo
€0.34 0.00 (0.00%)
As of 10/3/2025

About CORESTATE Capital Stock (ETR:CCAP)

Advanced

Key Stats

Today's Range
€0.33
€0.34
50-Day Range
€0.26
€0.35
52-Week Range
€0.26
€0.76
Volume
416 shs
Average Volume
N/A
Market Capitalization
€55.89 million
P/E Ratio
N/A
Dividend Yield
741.84%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CCAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CCAP Stock News Headlines

CORESTATE Capital (ETR:CCAP) Stock Price Up 2.4% - Here's Why
Tilson: “I’m watching HOOD”
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
Corestate Capital Holding S.A.
Corestate Capital Holding SA
Wells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)
See More Headlines

CCAP Stock Analysis - Frequently Asked Questions

CORESTATE Capital's stock was trading at €0.36 at the start of the year. Since then, CCAP stock has decreased by 6.4% and is now trading at €0.34.

Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), ARAVIVE (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Real Estate Services
Sub-Industry
Financial Services
Current Symbol
ETR:CCAP
CIK
N/A
Fax
N/A
Employees
446
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
(€21.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.01
Net Income
-€3.50 billion
Net Margins
-1,143.36%
Pretax Margin
N/A
Return on Equity
-269.30%
Return on Assets
-7.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
0.17

Sales & Book Value

Annual Sales
€306.04 million
Price / Sales
0.18
Cash Flow
€0.57 per share
Price / Cash Flow
0.60
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
165,831,023
Free Float
N/A
Market Cap
€55.89 million
Optionable
Not Optionable
Beta
1.03
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ETR:CCAP) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners